RMD ResMed|
$220.69 -0.97%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
-0.97%
YTD
-22.10%
P/E
20.88
P/B
4.29
ROE
23.9%
Div yield
1.3%
Beta
0.41
Market cap
$31.8B
RSI (14)
46
Next earnings
Oct 22, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$223.90
Close
$220.69
VWAP (n/a)
—
Day high
$225.23
Day low
$219.96
Volume
973K
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
ResMed (RMD): Buy, Sell, or Hold Post Q2 Earnings?
Yahoo Finance · Oct 5
Resmed to Report First Quarter Fiscal 2027 Earnings on October 29, 2026
Yahoo Finance · Oct 1
Is ResMed A Better Way Than Stryker To Own Medical Device Growth?
Yahoo Finance · Sep 28
ResMed Targets 12%-14% EPS Growth as GLP-1 Patients Lift Sleep Therapy Demand
Yahoo Finance · Sep 21
ResMed Inc. (RMD)’s Sleep Apnea Leadership Supports Growth Despite Rising Competitive Pressures
Yahoo Finance · Sep 19
Sleep Device Maker ResMed Gets an Upgrade. Analysts See a Lot to Like.
Yahoo Finance · Sep 15
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
8-K Sep 1, 2026 View → 8-K Aug 17, 2026 View → 10-K Aug 13, 2026 View → 8-K Aug 6, 2026 View → 8-K Jul 7, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell RMD. Try it in the Lab to size a position and see the risk.